Elastase and cathepsin G from primed leukocytes cleave vascular endothelial cadherin in hemodialysis patients

Meital Cohen-Mazor, Rafi Mazor, Batya Kristal, Shifra Sela

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

Aims. To test the hypothesis that primed PMNLs in blood of chronic kidney disease patients release the active form of elastase and cathepsin G causing degradation of vital proteins and promote tissue damage. Methods. RT-PCR, immunocytochemical staining, immunoblotting, and FACS analyses were used to study these enzymes in hemodialysis patients (HD) versus healthy normal controls (NC). Using PMNLs and endothelial cells cocultivation system we measure the effect of HD PMNLs on the endothelial VE-cadherin, an essential protein for maintaining endothelial integrity. Results. Levels of elastase and cathepsin G were reduced in PMNLs of HD patients, while mRNA enzymes levels were not different. Elevated levels of the active form of these enzymes were found in blood of HD patients compared to NC.HD plasma had higher levels of soluble VE-cadherin present in three molecular forms: whole 140 kDa molecule and two fragments of 100 and 40 kDa. Cocultivation studies showed that primed PMNLs cleave the endothelial cadherin, resulting in a 100 kDa fragment. Conclusions. Elastase and cathepsin G are elevated in the plasma of HD patients, originating from primed PMNLs. In these patients, chronic elevation of these enzymes contributes to cleavage of VE-cadherin and possible disruption of endothelial integrity.

Original languageEnglish
Article number459640
JournalBioMed Research International
Volume2014
DOIs
StatePublished - 2014

Fingerprint

Dive into the research topics of 'Elastase and cathepsin G from primed leukocytes cleave vascular endothelial cadherin in hemodialysis patients'. Together they form a unique fingerprint.

Cite this